Recently STAC3 (SH3 and cysteine-rich containing protein 3) has been identified as an essential regulator of calcium channel trafficking and function in skeletal muscle excitation--contraction (EC) coupling and a mutation in STAC3 has been linked to the severe muscle disease Native American myopathy (NAM) ([@r1], [@r2]). Expression of STAC3 is restricted to skeletal muscle, where STAC3 associates with the voltage-gated calcium channel Ca~V~1.1 and is involved in mediating voltage-induced calcium release from the sarcoplasmic reticulum ([@r3], [@r4]). In nonmuscle cells, STAC3 was shown to facilitate functional membrane expression of Ca~V~1.1 and alter the current properties of Ca~V~1.2 ([@r5]), suggesting a role of STAC proteins as an L-type calcium channel (Ca~V~1) regulator. STAC3 belongs to a family of adaptor proteins that comprises two additional isoforms, STAC1 and STAC2, which are highly expressed in the brain ([@r1]).

All three STAC proteins contain one C1 domain and two SH3 protein interaction domains ([@r6]). We previously demonstrated that the stable association of STAC3 to the Ca~V~1 channel complex in the triads of skeletal muscle relies on the C1 domain ([@r7]). In contrast, the NAM mutation, which impairs EC coupling and is located in the SH3-1 domain of STAC3 ([@r2][@r3]--[@r4]), did not abolish the interaction with the calcium channel ([@r2], [@r4], [@r7]). We therefore proposed that STAC3 establishes multiple interactions: one through the C1 domain, responsible for the stable anchoring of STAC3 to the channel, and another one through the SH3-1 domain, involved in EC coupling ([@r7]). Using X-ray crystallography, we recently identified the II-III loop of Ca~V~1 channels as the SH3-1 binding domain. Mutation of the three amino acids of Ca~V~1.1 critical for this interaction resulted in impaired EC coupling, similarly to the effects of introducing the NAM mutation in the SH3-1 domain ([@r6]). However, the molecular domain of Ca~V~1 channels responsible for the interaction with the C1 domain of STAC proteins remained to be discovered.

Here, we used a systematic domain swapping and mutagenesis approach to identify this STAC interaction site in Ca~V~1.2. Surprisingly the IQ domain in the C terminus of Ca~V~1.2 turned out to be essential for the association of STAC proteins, and the critical residues for STAC association overlap with those known to interact with the C-lobe of calcium-calmodulin (Ca/CaM) and to mediate calcium-dependent inactivation (CDI). Accordingly, our electrophysiological analysis of inactivation properties showed that STAC proteins inhibit CDI of Ca~V~1.2, but not of Ca~V~2.1 or of a Ca~V~1.2 chimera containing the IQ domain of Ca~V~2.1. These results suggest that neuronal STAC proteins represent a class of L-type calcium channel (Ca~V~1) regulators, which modulate negative feedback regulation of L-type calcium channels by interfering with the functional interaction of CaM with the IQ domain in the C terminus of Ca~V~1.2.

Results {#s1}
=======

The Proximal C Terminus of Ca~V~1.2 Is Crucial for the Interaction with STAC Proteins. {#s2}
--------------------------------------------------------------------------------------

In dysgenic (Ca~V~1.1^−/−^) myotubes, heterologously expressed Ca~V~1 channel are targeted to junctions between the sarcoplasmic reticulum and the plasma membrane or T-tubules, henceforth collectively referred to as triads, resulting in a characteristically clustered distribution pattern ([Fig. 1*A*](#fig01){ref-type="fig"}). In the absence of a Ca~V~1 subunit, heterologously expressed STAC-GFP proteins are diffusely distributed throughout the cytoplasm of the myotubes ([@r5], [@r7]). Upon reconstitution of dysgenic myotubes with Ca~V~1.2, all three STAC isoforms, to different extents, redistributed from the cytoplasm to the triads, indicating that STAC proteins form complexes with Ca~V~1.2 ([@r7]). Recently we identified the C1 domain of STAC3 as crucial interaction site with Ca~V~1.2 ([@r7]). Here we set out to identify the corresponding interaction site in Ca~V~1.2.

![The PCT of Ca~V~1.2 is crucial for the interaction with STAC3. (*A--D*, *Upper*) Cartoons showing the cytosolic domains of Ca~V~1.2 (blue) substituted with the corresponding regions of Ca~V~2.1 (N terminus, I-II loop, III-IV loop, PCT; red) or of the Musca channel (II-III loop; black). The Ca~V~1.2 triad targeting sequence (yellow) is maintained in all chimeras. (*Lower, Right*) Representative immunofluorescence images of dysgenic myotubes expressing the indicated chimeric Ca~V~1.2 channel and STAC3-GFP. (Scale bars, 10 μm.) (*Lower, Right*) Color overlay of Ca~V~β~1a~ (red) and STAC3-GFP staining (green); 4× magnification of regions indicated by blue rectangle. (Scale bars, 5 μm.) The numbers indicate the percentage of myotubes in which STAC3-GFP was coclustered with the channel chimera (*n* = 3, *n* = 90). (*A*) STAC3-GFP showed triad targeting in the majority of the dysgenic myotubes expressing Ca~V~1.2, Ca~V~1.2-NT~A~ or Ca~V~1.2-I-II~A~. Ca~V~1.2-II-III~M~, and Ca~V~1.2-III-IV~A~ failed to localize in the triads of the myotubes, precluding analysis of STAC3-GFP association (n.d.). STAC3-GFP colocalized also with Ca~V~1.2-Δ1800 (*B*), but not in myotubes expressing Ca~V~1.2-PCT~A~ (*C*), indicating that the PCT of Ca~V~1.2 is crucial for the interaction with STAC proteins. (*D*) C-terminal chimera A was not targeted to the triads, preventing analysis of association of STAC3-GFP. Chimera B was targeted to the triads and STAC3-GFP colocalized in clusters, similarly to the control Ca~V~1.2-Δ1800. Chimera C was targeted to the triads; however, it failed to recruit STAC3-GFP to the channel complex, indicating that amino acids 1,641--1,668 are crucial for the STAC interaction.](pnas.1715997115fig01){#fig01}

Ca~V~α1 subunits contain five large cytoplasmic domains representing putative binding sites for cytoplasmic modulator and effector proteins: namely, the N terminus; the I-II, II-II, III-IV loops; and the C terminus ([@r8], [@r9]). We hypothesized that if any of these cytoplasmic regions of Ca~V~1.2 contains sequences essential for the binding of STAC proteins, replacing it with the corresponding sequences of distantly related calcium channels would lead to loss of STAC association. Therefore, we constructed chimeras in which each of the cytoplasmic domains of Ca~V~1.2 was replaced with the corresponding region of the neuronal Ca~V~2.1 channel. Because the II-III loop of Ca~V~2.1 is about three times longer than that of Ca~V~1.2, a chimera with the II-III loop of the domestic fly channel (*Musca domestica*), which is very dissimilar in sequence but similar in size, was constructed instead ([@r10]) ([Fig. 1*A*](#fig01){ref-type="fig"}, *Upper*).

To analyze the incorporation of STAC proteins into the calcium channel complex, we coexpressed the channel chimeras with STAC3-GFP, the isoform that previously showed the highest degree of colocalization with Ca~V~1.2 in dysgenic myotubes ([@r7]). We labeled STAC3-GFP with a GFP antibody and the channel chimeras with an antibody against the β~1a~ subunit, as this antibody combination could be applied to all channel constructs. The two chimeras in which either the N terminus or the I-II loop of Ca~V~1.2 was replaced by that of Ca~V~2.1 (Ca~V~1.2-NT~A~ and Ca~V~1.2-I-II~A~) were localized in the triads of the myotubes, as expected. STAC3-GFP coclustered with the channel complex in the great majority of the myotubes (99 ± 1% for Ca~V~1.2-NT~A~ and 92 ± 1% for Ca~V~1.2-I-II~A~), similarly to the wild-type Ca~V~1.2 (98 ± 1%), indicating that these Ca~V~1.2 intracellular domains are not essential for the association with STAC proteins ([Fig. 1*A*](#fig01){ref-type="fig"}). Unfortunately, the chimeras in which the II-III loop was replaced with that of the *Musca* channel (Ca~V~1.2-II-III~M~) or the III-IV loop with that of Ca~V~2.1 (Ca~V~1.2-III-IV~A~) failed to target to the triads of the myotubes ([Fig. 1*A*](#fig01){ref-type="fig"}). Electrophysiological analysis revealed that Ca~V~1.2-II-III~M~ was not functionally expressed, and that the currents of Ca~V~1.2-III-IV~A~ were dramatically reduced compared with Ca~V~1.2 ([Fig. S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental) and [Table S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). Because Ca~V~1.2-II-III~M~ and Ca~V~1.2-III-IV~A~ were not effectively targeted to the triads, the potential involvement of these cytoplasmic loops in the association of Ca~V~1.2 with STAC proteins could not be assessed using this approach.

Examining the importance of the large C terminus for the interaction with STAC proteins required a more elaborate approach. Because the C terminus is subjected to proteolytic cleavage ([@r11]), we first examined the importance of the distal C terminus for STAC3-GFP binding. The C-terminally truncated Ca~V~1.2-Δ1800 localized in the triads of dysgenic myotubes and STAC3-GFP colocalized in clusters in the great majority of the myotubes (97 + 1%), indicating that the distal C terminus is dispensable for the interaction with STAC proteins ([Fig. 1*B*](#fig01){ref-type="fig"}). Next, we replaced the proximal C-terminal (PCT) region with the corresponding region of Ca~V~2.1, yet sparing the triad targeting signal (amino acids 1,681--1,700) ([@r12]). As expected, this chimera, Ca~V~1.2-PCT~A~, was localized in the triads of the myotubes. However, STAC3-GFP failed to associate with this chimeric channel and remained diffusely distributed throughout the cytoplasm ([Fig. 1*C*](#fig01){ref-type="fig"}). Thus, the PCT of Ca~V~1.2 contains specific sequences that are essential for the association of STAC with the calcium channel.

STAC Proteins Interact with the IQ Domain (1,641--1,668) of Ca~V~1.2. {#s3}
---------------------------------------------------------------------

To narrow down the sequence in the PCT of Ca~V~1.2 critical for STAC association, we further subdivided Ca~V~1.2-PCT~A~ (1,507--1,668) into three smaller regions and replaced them with the corresponding sequences of Ca~V~2.1 ([Fig. 1*D*](#fig01){ref-type="fig"}): region A (1,507--1,603), which forms a conserved structural unit ([@r13]); region B (1,604--1,640), containing the pre-IQ domain and extending to the end of the currently solved calcium channel structure ([@r13]); and region C (1,641--1,668), the remaining 28 amino acids containing the IQ CaM binding domain. Chimera A failed to target into the triads of the myotubes, precluding analysis of its potential role in STAC3-GFP interactions ([Fig. 1*D*](#fig01){ref-type="fig"}). Chimera B was targeted to the triads, and STAC3-GFP associated with it at a level (99 ± 1%) comparable to the wild-type Ca~V~1.2-Δ1800 channel (96 ± 2%). Thus, an involvement of this sequence in Ca~V~1.2-STAC association can be excluded. Most importantly, chimera C was correctly targeted to the triads, but STAC3-GFP failed to associate with the channel complex in all analyzed myotubes (0 ± 0%).

To examine whether the importance of this Ca~V~1.2 sequence (amino acids 1,641--1,668) is specific for STAC3 or it is also essential for recruiting other STAC isoforms into the channel complex, we tested STAC1-GFP association to chimera C. While STAC1-GFP colocalized in clusters with Ca~V~1.2-Δ1800 in 70 ± 3% of the differentiated myotubes, it completely failed to associate with chimera C (0 ± 0%), but remained diffusely localized in the cytoplasm ([Fig. S2](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). Thus, binding to the C-terminal 1,641--1,668 sequence may be a general mechanism for the association of STAC proteins to Ca~V~1.2.

STAC3 Recruitment into the Ca~V~1.2 Channel Complex Requires Conserved and Nonconserved Residues of the IQ Motif. {#s4}
-----------------------------------------------------------------------------------------------------------------

The 28-amino acid residues of Ca~V~1.2 that in chimera C were replaced by the corresponding sequence of Ca~V~2.1 contain the IQ domain (1,644--1,665) flanked on each side by three additional amino acids ([Fig. 2*A*](#fig02){ref-type="fig"}). To identify the residues that are important for interacting with STAC proteins, we performed a systematic alanine scanning mutagenesis of the 22 amino acids comprising the IQ domain and analyzed whether mutation of individual residues affected the ability of STAC3-GFP to associate with Ca~V~1.2-Δ1800 clusters in the triads of dysgenic myotubes ([Fig. 2*A*](#fig02){ref-type="fig"} and [Table S2](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). When we mutated the residues that are conserved between Ca~V~1.1 and Ca~V~1.2, both of which associate with STAC3 but are different in Ca~V~2.1, which does not associate with STAC (in blue in [Fig. 2*A*](#fig02){ref-type="fig"}), we identified two amino acid substitutions that significantly reduced the STAC3-GFP coclustering compared with the wild-type channel (96 ± 1%): that is, F1658 (39 ± 9%) and F1648 (64 ± 6%). Conversely, mutation of the residues that are not conserved between Ca~V~1.1 and Ca~V~1.2 (in green in [Fig. 2*A*](#fig02){ref-type="fig"}) had no effect on STAC3 association. When we extended the mutagenesis to the residues that are conserved among all three calcium channels (in yellow in [Fig. 2*A*](#fig02){ref-type="fig"}), we identified two additional mutations that significantly reduced the ability of STAC3-GFP to associate with the calcium channel, I1654 (12 ± 6%) and R1659 (66 ± 7%). Because I1654 and R1659 are conserved both in calcium channels that recruits STAC3 (Ca~V~1.1 and Ca~V~1.2) and in a calcium channel that does not (Ca~V~2.1), these residues are important for STAC association but do not contribute to the channel specificity of the interaction. F1658 and F1648, on the other hand, are conserved only in STAC interacting channels and therefore may determine the specificity of the interaction.

![Identification of the amino acid residues crucial for the interaction with STAC proteins. (*A*) Amino acid sequences of the IQ domain of Ca~V~1.2, Ca~V~1.1, and Ca~V~2.1: yellow, residues conserved in all three paralogs; green, conserved between Ca~V~1.2 and Ca~V~2.1; blue, conserved between Ca~V~1.2 and Ca~V~1.1. Numbers indicate the amino acid position of Ca~V~1.2. The bar graph shows the percentage of transfected myotubes in which STAC3-GFP coclustered with the Ca~V~1.2 IQ point mutant. Values obtained for each point mutation are indicated in [Table S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental). ANOVA *F*~(21,~ ~49)~ = 32.41, *P* \< 0.0001. The three asterisks (\*\*\*) represent values for Tukey post hoc analysis. (*B*) Position of F1648A, I1654A, F1658A, and R1659A in the secondary structure of the IQ domain of Ca~V~1.2 (PDB ID code 2BE6).](pnas.1715997115fig02){#fig02}

Coexpression of STAC3 Abolishes CDI in Ca~V~1.2. {#s5}
------------------------------------------------

Earlier X-ray crystallography demonstrated that the IQ domain of Ca~V~1.2 forms an α-helix ([@r14]). The two residues, I1654 and F1658, mutation of which caused a larger decrease in STAC3 association are positioned side-by-side in adjacent turns of the helix and oriented in the same direction. In contrast, the two residues, F1648 and R1659, mutation of which caused a milder decrease of STAC3 association, are oriented in the opposite direction. Structure modeling suggests that R1659 stabilizes the helical domain structure by an intramolecular interaction with E1656 ([Fig. 2*B*](#fig02){ref-type="fig"}). Importantly, several earlier studies demonstrated that the two crucial residues for STAC association, I1654 and F1658, make contacts with the C-lobe of Ca/CaM and are thus important for its function in CDI ([@r14][@r15]--[@r16]). Therefore, we hypothesized that association of STAC proteins with the Ca~V~1.2 C terminus may interfere with binding of CaM or its allosteric effects on channel conformation, and thereby prevent CDI. To test this hypothesis, we analyzed the inactivation properties of Ca~V~1.2 currents expressed in the absence and presence of STAC3 in tsA201 cells using whole-cell patch-clamp recordings.

First, we compared current inactivation with calcium and barium as charge carriers. As previously shown, in cells transfected with Ca~V~1.2, calcium currents show fast inactivation kinetics and are strongly reduced at the end of a 500-ms depolarization step, whereas barium currents showed significantly slower and weaker inactivation ([Fig. 3*A*](#fig03){ref-type="fig"}) ([@r15], [@r17]). The inactivation measured with barium as a charge carrier represents voltage-dependent inactivation; the additional component with calcium as a charge carrier is CDI and depends on the interaction of Ca/CaM with the IQ domain of Ca~V~1.2 ([@r18]). Inactivation in calcium and barium was quantitatively assessed as the residual current amplitude after 250 ms of the 500-ms voltage step normalized to the peak current (*I*~res250~/*I*~pk~). Thus, CDI of Ca~V~1.2 is evident in the significant difference in *I*~res250~/*I*~pk~ between calcium and barium currents (*P* \< 0.0001) ([Fig. 3*A*](#fig03){ref-type="fig"} and [Table S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). Notably, upon coexpression of STAC3, this difference in inactivation in calcium and barium was completely abolished (*P* = 0.82) ([Fig. 3*B*](#fig03){ref-type="fig"}), indicating that in the presence of STAC3 the remaining inactivation of Ca~V~1.2 currents is purely voltage-dependent inactivation. Coexpression of STAC3 had no significant effect on the voltage-dependence of current activation ([Fig. S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental) and [Table S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). To directly compare net CDI of Ca~V~1.2 in the presence and absence of STAC3, we calculated the quotient of the normalized *I*~Ca~ and mean *I*~Ba~ over time ([@r19], [@r20]) ([Fig. 3*C*](#fig03){ref-type="fig"}). This analysis clearly demonstrates the robust CDI of Ca~V~1.2 in the absence of STAC3 and its complete loss upon coexpression of STAC3 (*P* \< 0.0001). This effect is reminiscent of the effects of Ca~V~1.2 mutations affecting CaM binding ([@r15]) or of dominant-negative CaM mutants ([@r17]), and thus indicates a role of STAC3 in blocking the function of CaM in Ca~V~1.2.

![STAC3 coexpression abolishes CDI of Ca~V~1.2 but not of Ca~V~2.1 in an IQ domain dependent manner. Representative normalized calcium and barium currents at *V*~max~ of tsA201 cells expressing Ca~V~1.2 (*A*), Ca~V~2.1 (*D*), or Ca~V~1.2-IQ~A~ (*G*). Internal calcium buffering with 0.5 mM EGTA. Significant differences in the relative residual current amplitude after 250 ms (*I*~res250~/*I*~pk~) in calcium and barium indicate robust CDI (\*\*\*\**P* \< 0.0001 for Ca~V~1.2; \*\**P* = 0.002 for Ca~V~2.1; \*\*\*\**P* \< 0.0001 for Ca~V~1.2-IQ~A~). (*B*) Upon coexpression of STAC3, the CDI of Ca~V~1.2 currents was abolished, as in calcium and barium currents inactivated to the same extent and *I*~res250~/*I*~pk~ were comparable (n.s., *P* = 0.82). In contrast, CDI of Ca~V~2.1 and Ca~V~1.2-IQ~A~ was unaffected by coexpression of STAC3 (\**P* = 0.012 and \*\*\*\**P* \< 0.0001, respectively) (*E*--*H*). Representative normalized net CDI (−I~Ca~/I~Ba~) of Ca~V~ currents in the absence or the presence of STAC3 and relative I~res250~/I~pk~ demonstrate that STAC3 coexpression abolishes the CDI of Ca~V~1.2 (\*\*\*\**P* \< 0.0001) (*C*), but not of Ca~V~2.1 and Ca~V~1.2-IQ~A~ (n.s., *P* = 0.32 and *P* = 0.37, respectively). (*F*--*I*) *P* values are from unpaired *t* test.](pnas.1715997115fig03){#fig03}

In contrast to Ca~V~1.2, STAC3 does not associate with the C terminus of Ca~V~2.1 ([Fig. 1*C*](#fig01){ref-type="fig"}). Therefore, we expected that coexpression of STAC3 and Ca~V~2.1 will not block CDI of Ca~V~2.1 currents. Indeed, calcium and barium currents recorded in the absence or presence of STAC3 showed a similar degree of inactivation ([Fig. 3 *D* and *E*](#fig03){ref-type="fig"}). The mean residual currents *I*~res250~/*I*~pk~ of calcium and barium did not differ in the absence (*P* = 0.002) or in the presence of STAC3 (*P* = 0.012). In addition, analysis of net CDI of Ca~V~2.1 showed no significant difference in *I*~res250~/*I*~pk~ with and without STAC3 (*P* = 0.32) ([Fig. 3*F*](#fig03){ref-type="fig"}), demonstrating that STAC3 has no effect on CDI of Ca~V~2.1 currents.

To examine whether inhibition of CDI of Ca~V~1.2 currents depends on the specific interaction of STAC3 with the Ca~V~1.2 IQ domain, we constructed a Ca~V~1.2-IQ~A~ chimera, in which the IQ domain of the full-length C terminus of Ca~V~1.2 has been substituted with the corresponding sequence of Ca~V~2.1. If our hypothesis was correct, this sequence substitution should abolish the effect of STAC3 on the CDI of Ca~V~1.2. We first examined whether CaM is still able to bind to this IQ motif chimera and cause inactivation. This was the case, as in the absence of STAC3, we observed a significant difference in *I*~res250~/*I*~pk~ between calcium and barium currents (*P* \< 0.0001) ([Fig. 3*G*](#fig03){ref-type="fig"}). Most importantly, upon coexpression of STAC3 the sizable difference between calcium and barium currents was maintained (*P* \< 0.0001) ([Fig. 3*H*](#fig03){ref-type="fig"}), indicating that, as hypothesized, STAC3 did not abolish CDI in the Ca~V~1.2-IQ~A~ chimera. Furthermore, comparison of the net CDI of Ca~V~1.2-IQ~A~ currents in the presence or the absence of STAC3 revealed no significant difference (*P* = 0.37) ([Fig. 3*I*](#fig03){ref-type="fig"}). Together with our microscopy association analysis, this demonstrates that both the association of STAC3 and Ca~V~1.2 in the triads of dysgenic myotubes and the STAC3-induced suppression of CDI in Ca~V~1.2 currents expressed in tsA201 cells depend on the integrity and specificity of the IQ domain.

Neuronal STAC1 and STAC2 Isoforms Reduce CDI of Ca~V~1.2 Calcium Currents. {#s6}
--------------------------------------------------------------------------

So far we tested the effect of STAC3 on the inactivation of Ca~V~1.2, because it most potently associates with Ca~V~1.2, as evidenced by its superior recruitment to Ca~V~1.2 clusters in the triads of dysgenic myotubes ([@r7]), although Ca~V~1.2 and STAC3 are probably not expressed together in native tissue ([@r1]). Conversely, STAC1 and STAC2 are expressed in a variety of tissues, including the brain, where Ca~V~1.2 is also abundant. We therefore addressed the question as to whether the neuronal isoforms, STAC1 and STAC2, are also able to oppose CDI of Ca~V~1.2. When recorded with mild cytoplasmic calcium buffering (0.5 mM EGTA), coexpression of STAC1 or STAC2 in tsA201 cells did not result in a total loss of CDI, as significant differences in *I*~res250~/*I*~pk~ were detected between calcium and barium currents in the presence of both STAC1 and STAC2 ([Fig. 4 *A* and *B*](#fig04){ref-type="fig"} and [Table S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)) (*P* \< 0.0001). Nevertheless, when comparing the net CDI of Ca~V~1.2 calcium currents in the absence or presence of STAC1 or STAC2, it became evident that CDI was reduced and this reduction of *I*~res250~/*I*~pk~ was significant in the case of STAC1 (*P* = 0.029) ([Fig. 4*C*](#fig04){ref-type="fig"}). Further analysis of the kinetics of calcium current inactivation demonstrated that coexpression of either STAC1 or STAC2 caused a significant decrease in the fraction of the fast component of inactivation (*P* = 0.0001) ([Fig. S4*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)), without significantly shifting the voltage dependence of activation ([Fig. S4*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental) and [Table S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). When we repeated this experiment with higher internal calcium buffering (10 mM EGTA), coexpression of STAC1 resulted in a complete loss of CDI, and coexpression of STAC2 in a nearly complete loss of CDI ([Fig. 4 *D*--*F*](#fig04){ref-type="fig"} and [Table S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)), without significantly shifting the voltage dependence of activation ([Fig. S4*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental) and [Table S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). Together, these results demonstrate that STAC1 and STAC2 also interfere with CDI of Ca~V~1.2 channels, although at a somewhat lower degree compared with STAC3, and that the extent of the inhibition depends on the internal calcium buffering capacity of the cell. The lower extent of this functional effect correlates with the lower ability of STAC1 and STAC2 to associate with the Ca~V~1.2 complex ([@r7]).

![STAC1 and STAC2 impede CDI of Ca~V~1.2 currents. Representative normalized calcium and barium Ca~V~1.2 currents in the presence of STAC1 (*A*) or STAC2 (*B*) using mild intracellular calcium buffering (0.5 mM EGTA). Significant differences in *I*~res250~/*I*~pk~ in calcium and barium indicate CDI (\*\*\*\**P* \< 0.0001, unpaired *t* test). (*C*) Analysis of the net CDI (−*I*~Ca~/*I*~Ba~) of Ca~V~1.2 indicates that with 0.5 mM EGTA in the internal solution coexpression of STAC1 and STAC2 slows down CDI to different extents. ANOVA *F*~(2,~ ~24)~ = 7.44; *P* = 0.0029; *P* values in the figure are from Tukey post hoc analysis, \*\**P* = 0.002. (*D*) With strong intracellular calcium buffering (10 mM EGTA) coexpression of STAC1 resulted in loss of CDI, as the calcium and barium currents inactivated similarly and *I*~res250~/*I*~pk~ were not significantly different (n.s., *P* = 0.70). (*E*) Coexpression of STAC2 strongly reduced CDI (\**P* = 0.02). (*F*) Representative normalized net CDI of Ca~V~ currents and relative *I*~res250~/*I*~pk~ demonstrate that STAC1 abolishes and STAC2 severely reduces the CDI of Ca~V~1.2. ANOVA *F*~(2,~ ~19)~ = 1.319; *P* \< 0.0001; *P* values in the figure are from Tukey post hoc analysis, \*\*\*\**P* \< 0.0001.](pnas.1715997115fig04){#fig04}

Finally, we examined whether CDI of Ca~V~2.1 currents is unaffected by STAC1 coexpression, as it is by STAC3. Indeed, the difference between Ca~V~2.1 calcium and barium currents was not diminished by coexpression of STAC1 and the calculated net CDI of Ca~V~2.1 was not significantly different with and without STAC1 ([Fig. S5](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental) and [Tables S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental) and [S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental)). Thus, muscle and neuronal STAC isoforms specifically alter CDI of Ca~V~1.2, but not that of Ca~V~2.1. Due to its efficient interaction with the Ca~V~1.2 IQ domain, STAC3 completely abolishes CDI, whereas the weaker interactions of the STAC1 and STAC2 isoforms essentially slow down Ca~V~1.2 current inactivation kinetics to different degrees, depending on the internal calcium buffering.

Discussion {#s7}
==========

The results of our study demonstrate that: (*i*) amino acids 1,641--1,668 in the C terminus of Ca~V~1.2 are essential for the recruitment of STAC proteins to the calcium channel when expressed in the triads of dysgenic myotubes; (*ii*) this sequence contains the IQ CaM interaction domain and that the critical residues responsible for interaction with STAC proteins overlap with those known to bind the C-lobe of CaM; (*iii*) that, in variance to the interactions with CaM, the IQ/STAC interaction is specific for the family of Ca~V~1 channels; (*iv*) STAC proteins inhibit CDI of Ca~V~1.2, but not of Ca~V~2.1, and substitution of the Ca~V~1.2 IQ domain with that of Ca~V~2.1 abolishes this effect; and (*v*) the potency of STAC/Ca~V~1.2 association and of quenching CDI differs between the three STAC isoforms congruently.

The importance of the Ca~V~1.2 IQ domain for the interaction with STAC proteins is established by its essential role in recruiting STAC to the triads and in inhibition of CDI in response to STAC coexpression. This twofold effect is not surprising, considering the known role of this IQ motif as the binding site for the effector of CDI, the C-lobe of the calcium sensor CaM ([@r14]), and considering our finding that STAC and CaM interactions depend on the same amino acids in the IQ motif ([Fig. 2](#fig02){ref-type="fig"}). However, two of the four crucial residues for STAC association are not conserved in Ca~V~2 channels and, consequently, the STAC/IQ interaction is specific for Ca~V~1 channels. Thus, we identified STAC proteins as specific modulators of L-type calcium channels.

In a previous study we demonstrated the importance of the C1 domain of STAC proteins for their recruitment to the channel complex in dysgenic myotubes ([@r7]). Furthermore, CDI of Ca~V~1.2 can be abolished by a truncated STAC3 containing the C1 domain but lacking the SH3 domains ([@r6]). Thus, it is likely that the C1 domain in STAC proteins and the IQ domain in Ca~V~1 channels are the corresponding sites responsible for the association of STAC with the channel complex in the triads and for interference with CDI. This, however, does not imply that the IQ domain is the only site in Ca~V~1 channels involved in interactions with STAC proteins. For example, additional interaction sites may reside in any of the three cytoplasmic sequences (II-III loop, III-IV loop, PCT), which were unamenable for testing in our triad targeting assay. Indeed, in a recent X-ray analysis study, we solved the structure of tandem-SH3 domains of STAC in complex with the II-III loop of Ca~V~1.1. Introducing the NAM mutation in the SH3-1 domain or mutations in the corresponding binding site of the II-III loop both abolished the interaction and impaired EC coupling ([@r6]). However, we and others previously showed that the NAM mutation in STAC3 did not prevent STAC3-Ca~V~1.1 association in skeletal myotubes ([@r2][@r3]--[@r4], [@r7]). Moreover, our present results demonstrate that in the absence of the Ca~V~1.2 IQ domain possible additional STAC binding site are not sufficient for recruiting heterologously expressed STAC proteins into the triads of dysgenic myotubes. Therefore, the interaction of STAC3 and Ca~V~1.1 seems to depend on at least two distinct sites with different functions. The C1/IQ interaction is crucial for the stable association of the two proteins in skeletal muscle triads and for the modulation of inactivation properties of Ca~V~1.2 currents, whereas the SH3-1/II-III loop interaction is of functional importance for EC coupling.

The molecular mechanism by which STAC proteins modulate CDI in Ca~V~1.2 requires further investigation. Because STAC association to Ca~V~1.2 and CaM C-lobe--mediated CDI depend in part on the same IQ motif residues, STAC might block CDI by competing with CaM for the same binding site. Because both calcium-free and calcium-occupied CaM can bind to the IQ domain, blocking either interaction may be sufficient for abolishing CDI. Alternatively, the high affinity of Ca/CaM binding to the IQ domain ([@r21]) favors the possibility that STAC proteins interact with the Ca/CaM/IQ domain complex at the C terminus of Ca~V~1.2, thus preventing the conformational changes that trigger CDI. We further observed that the three STAC isoforms oppose CDI of Ca~V~1.2 currents in tsA201 cells to different degrees and that the rank order of how effectively each STAC isoform inhibited CDI (STAC3 \> STAC1 \> STAC2) correlated well with the efficiency at which they were recruited to the Ca~V~1.2 channel complex in myotubes ([@r7]). Thus, association of STAC proteins at the IQ domain with different affinities may explain their different potencies to interfere with CaM modulation.

Although we mapped the interaction site of STAC proteins using Ca~V~1.2, several lines of evidence suggest that the IQ domain is also required for association of STAC3 with Ca~V~1.1 and that this might be of functional importance in skeletal muscle. First, while we demonstrated that STAC3 interacts with Ca~V~1.1 as stably as the β~1a~ subunit ([@r7]), the measured affinity of the STAC SH3-1/II-III loop interaction is more than 100-fold weaker, suggesting that this site alone would not be sufficient for a stable interaction ([@r6]). Second, the four IQ residues critical for the STAC interaction are conserved among the IQ domains of Ca~V~1.1 and Ca~V~1.2, and mutation of three residues not conserved between these two isoforms did not weaken the STAC3/Ca~V~1.2 complex ([Fig. 2](#fig02){ref-type="fig"}). Therefore, it is likely that in skeletal muscle triads STAC3 association at the IQ motif of Ca~V~1.1 interferes with CaM function.

The notion that in skeletal muscle triads STAC3 association with the C terminus of Ca~V~1.1 prevails over CaM function is consistent with the essential functional role of STAC3 in EC coupling, as well as with the lacking inactivation of skeletal muscle calcium currents ([@r22]). Conversely, the earlier observation showing that mutation of the Ca~V~1.1 IQ motif to alanines (IQAA) resulted in the loss of EC coupling ([@r23]) could readily be explained by its disruptive effect on the association of STAC3 with Ca~V~1.1. Because in skeletal muscle L-type calcium currents are limited by several other mechanisms ([@r24]), negative feedback regulation of calcium influx by CDI may be irrelevant. Finally, interference of STAC3 with CaM function in skeletal muscle may also explain why inactivation kinetics of Ca~V~1.2 are dramatically reduced when it is expressed in skeletal myotubes, which endogenously express STAC3 ([@r25][@r26][@r27][@r28]--[@r29]).

Interestingly, cardiac muscle, in which Ca~V~1.2 is of central importance, does not express STAC proteins ([@r1]). In this tissue, limiting calcium influx by CDI appears to be of major importance, as mutations in Ca~V~1.2 and auxiliary subunits that prolong the activation of the cardiac channel result in arrhythmias, long QT disease, and Timothy syndrome ([@r30]). Interference with CDI by competing STAC proteins would be expected to exert similar undesired effects of prolongation of calcium currents.

In contrast, modulation of CDI in L-type calcium channels may be desirable in other excitable cells, including neurons. There, Ca/CaM-dependent regulation of presynaptic Ca~V~2 channels is subject to modulation by a variety of calcium-binding proteins, which compete for the same interaction domain ([@r31]). Similarly, STAC proteins could serve the complementary function by acting as modulators of CDI on the postsynaptic Ca~V~1 channels. Indeed, the expression patterns of STAC1 and STAC2 overlap with those of Ca~V~1.2 in several areas of the brain, as well as in smooth muscle and adrenal cells ([@r1]). Their weaker association with Ca~V~1.2 and their incomplete block of CDI compared with STAC3 is consistent with such a modulatory function, allowing inactivation of Ca~V~1.2 to be tuned by both the expression levels of STAC1 or STAC2 and by the specific calcium buffering capacity in different neuronal cell types. In conclusion, the identification of the IQ domain of Ca~V~1.2 as a crucial determinant for binding STAC proteins, and the observation that STAC proteins differentially oppose to Ca~V~1.2 CDI suggest a role of STAC proteins as Ca~V~1 regulators and adds them to the diverse group of proteins that tune the calcium entry in excitable cells.

Materials and Methods {#s8}
=====================

Cloning Procedures. {#s9}
-------------------

A detailed description of the constructs used is available in the [*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental).

Immunostaining and Image Processing. {#s10}
------------------------------------

Dysgenic myotubes were cultured, transfected and labeled as previously described ([@r7]). A detailed description is available in the [*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental).

Electrophysiological Recordings and Data Analysis. {#s11}
--------------------------------------------------

tsA201 cells expressing β~3~ and α~2~δ-1 were cultured as previously described ([@r32]). A detailed description of whole-cell patch clamp recordings and data analysis is available in the [*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715997115/-/DCSupplemental).
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